期刊文献+

凋亡相关基因在骨肉瘤细胞中的表达及其临床意义 被引量:4

Expression of apoptosis related genes in osteosarcoma cells and their clinical significance
原文传递
导出
摘要 目的探讨凋亡相关基因在骨肉瘤细胞中的表达及其临床意义。方法采用3个公认的骨肉瘤细胞株及1个成骨细胞株,提取总RNA,合成生物素标记的cRNA与Affymetrix Ge—neChip U133A芯片杂交,筛选差异表达的凋亡相关基因。利用MATLAB软件进行细胞凋亡通路的KEGG分析。结果以表达差异≥2.0倍为限,在Affymetrix HG—U133A芯片包含的所有基因中,3个骨肉瘤细胞株与成骨细胞株比较,一共筛选出7个差异表达的凋亡相关基因:3个上调基因(IKBKB、IL1R1和FAS),4个下调基因(TP53、PPP3CB、PPP3CC和APAF1)。利用MATLAB软件将7个差异表达的凋亡相关基因映射到KEGG的凋亡通路上。结论骨肉瘤是细胞增殖和细胞凋亡间平衡失调的结果,通过调控细胞凋亡相关基因的表达可以诱导肿瘤细胞凋亡,达到抗肿瘤目的。 Objective To explore the expression of apoptosis related genes in osteosareoma cells, and study their clinical significance in osteosarcoma. Methods Three well-known ATCC osteosarcoma cell lines and an osteoblastic cell line were collected. After the total RNA extraction,the finally synthesized biotinylated cRNAs were hybridized to Affymetrix GeneChip U133A arrays. Bioinformatics method was used to screen the apoptosis related genes which were differentially expressed. Results Using an entrance limit of ≥ 2.0,there were 3 up-regulated (IKBKB, ILl R1 and FAS) and 4 dowm-regulated apoptosis related genes (TP53 ,PPP3CB,PPP3CC and APAF1 ) identified by microarray which were commonly differentially expressed among all the three osteosarcoma cell lines in comparison with the osteoblastic cell line hfob1. 19. Conclusion Osteosarcoma is a result of disequilibrium between cell proliferation and apoptosis. Regulating the expression of apoptosis related genes may induce apoptosis of tumor cells, and achieve the purpose of anti-tumor.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2009年第6期707-709,共3页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30170955) 上海市科委重点基础科研项目(05JC14047)
关键词 骨肉瘤 基因表达 脱噬作用 Osteosarcoma Gene expression Apoptosis
  • 相关文献

参考文献14

  • 1李国东,蔡郑东,陈正军,卢雪峰,雷会宁,郑龙坡.基因微矩阵技术在骨肉瘤发病相关基因研究中的应用[J].中华实验外科杂志,2005,22(9):1094-1097. 被引量:5
  • 2Marina N, Gebhardt M, Teot L, et al. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist,2004,9:422-441.
  • 3Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet Cytogenet ,2003,145 : 1-30.
  • 4Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res,2000,28:27-30.
  • 5Lea RG, Riley SC, Antipatis C, et al. Cytokines and the regulation of apoptosis in reproductive tissues: a review. Am Jreprod Immunol, 1999,42 : 100-109.
  • 6Minoru NK,Madoka I, Kenya OM, et al. p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome. Mol Cancer Ther, 2005,4 : 625-631.
  • 7Vogelstein B, Kinzier KW. p53 function and dysfunction. Cell, 1992, 70:523-526.
  • 8Lowe SW, Bodis S, et al. p53 status and efficacy of cancer therapy in vivo. Science, 1994,266 : 807-810.
  • 9Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science, 1991,253:49-53.
  • 10Ferraro E, Corvaro M, Cecconi F. Physiological and pathological roles of Apafl and the apoptsome. J Cell Mol Med,2003,7:21-34.

二级参考文献12

  • 1Wolf M, EI-Rifai W, Tarkkanen M, et al. Novel findings in gene expression detected in human osteosarcoma by cDNA microarray. CancerGenet Cytogenet, 2000, 123 : 128-132.
  • 2Yu Y, Khan J, Khanna C, et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med, 2004, 10 : 175-181.
  • 3Khanna C, Wan X, Bose S, et al. The membrane-cytoskdeton linker ezrin is necessary for osteosarcoma metastasis. Nat Med, 2004, 10:182-186.
  • 4Rubin MA, VarambaUy S, Beroukhim R, et al. Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Cancer Res, 2004, 64 : 3814-3822.
  • 5Byrne JA, Tomasetto C, Gamier JM, et al. A screening method to identify genes commonly overexpressed in carcinomas and the identificatin of a novel complementary DNA sequence. Cancer Res, 1995, 55:2896-2903.
  • 6Thornton S, Anand N, Purcell D, et al. Not just for housekeeping:protein initiation and elongation factors in cell growth and tumorigenesis. JMol Med, 2003, 81 : 536-548.
  • 7Lee J. The role of protein elongation factor EeflA2 in ovarian cancer.Reprod Biol Endocrinol, 2003, 1:69.
  • 8Kristiansen G, Winzer K, Mayordomo E, et al. CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res, 2003, 9:4906-4913.
  • 9Trougakos IP, Gonos ES. Clusterin/apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol, 2002, 34 : 1430-1448.
  • 10Kau T, Way J, Silver PA, et al. Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer, 2004,4 : 106-117.

共引文献4

同被引文献36

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部